Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (241-250 of 315) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|May 7, 2015
Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantationMahmoud ElSawy, Barry E Storer, Michael A Pulsipher, et al.
Blood|July 2, 2002
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialMary E D Flowers, Pablo M Parker, Laura J Johnston, et al.
Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.
Transplantation|April 11, 2014
Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantationMarco Mielcarek, Anna Yasmine Kirkorian, Robert C Hackman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III studyFabrizio Carnevale-Schianca, Wendy Leisenring, Paul J Martin, et al.
Transplantation|September 14, 2006
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graftMurad Y Yunusov, Christian S Kuhr, George E Georges, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2002
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host diseaseTerry Furlong, Wendy Leisenring, Rainer Storb, et al.
Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.
Bone Marrow Transplantation|April 15, 2018
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allograftingAlessandro Busca, Roberto Passera, Enrico Maffini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for LymphomaSolomon A Graf, Jennifer E Vaughn, Thomas R Chauncey, et al.
Pageof 32

Showing results (241-250 of 315) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|May 7, 2015
Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantationMahmoud ElSawy, Barry E Storer, Michael A Pulsipher, et al.
Blood|July 2, 2002
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialMary E D Flowers, Pablo M Parker, Laura J Johnston, et al.
Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.
Transplantation|April 11, 2014
Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantationMarco Mielcarek, Anna Yasmine Kirkorian, Robert C Hackman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III studyFabrizio Carnevale-Schianca, Wendy Leisenring, Paul J Martin, et al.
Transplantation|September 14, 2006
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graftMurad Y Yunusov, Christian S Kuhr, George E Georges, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2002
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host diseaseTerry Furlong, Wendy Leisenring, Rainer Storb, et al.
Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.
Bone Marrow Transplantation|April 15, 2018
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allograftingAlessandro Busca, Roberto Passera, Enrico Maffini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for LymphomaSolomon A Graf, Jennifer E Vaughn, Thomas R Chauncey, et al.
Pageof 32